Early-life Oxytocin Rescues Hippocampal Synaptic Plasticity and Episodic Memory in a Mouse Model of Fragile X Syndrome

Cognitive disabilities including impairments to episodic memory are debilitating features of autism spectrum disorder (ASD). Here we report that early-life treatment with oxytocin (OXT) fully restores episodic memory and associated synaptic plasticity in a rodent model of an ASD. Fmr1-knockout (KO) mice -- which mimic the single gene mutation in Fragile X Syndrome -- failed to encode three basic elements of an episode (identity, location, and temporal order) during a first time, unrewarded encounter with a set of cues. Intranasal administration of OXT during the second postnatal week eliminated each of these impairments in mice tested in adulthood. OXT treatment during the second, but not fifth, postnatal week also corrected pronounced defects in two distinct forms of hippocampal Long-Term Potentiation (LTP). Rescue of LTP in lateral perforant path (LPP) to dentate gyrus synapses was linked to recovery of NMDAR-gated synaptic responses, which are otherwise profoundly reduced in the mutant LPP. LTP induced by a threshold theta burst stimulation protocol in CA3-CA1 synapses was severely impaired in adult Fmr1-KOs as was a previously unreported post-induction growth phase for potentiation. Both effects were restored in adult Fmr1-KOs given early OXT treatment. Infusion of OXT into adult Fmr1-KO hippocampal slices normalized LTP in CA1 but had no effect on the defective potentiation (or NMDAR-mediated EPSCs) at LPP-dentate gyrus synapses. These results show that severe, autism-related defects in cognition critical to memory, as evident in a rodent model, are reversible and that an early-life therapeutic intervention can effect an enduring restoration of function.